Spanish researchers who observed hair repigmentation among patients with non-small-cell lung cancer who responded to immunotherapeutic drugs against programmed cell death protein 1 and its ligand believe that the side effect could serve as a potential marker of response.

High neutrophil counts, leflunomide treatment, and the absence of anti-citrullinated protein antibodies are associated with increased risk for serious infection among patients with rheumatoid arthritis who are treated with tocilizumab, researchers report.

Patients with rheumatoid arthritis who stop tumor necrosis factor inhibitor therapy experience worse patient-reported outcomes in the short-term than those who continue treatment, analysis of trial data suggests.

Nearly a quarter of all cancers diagnosed in the European Union between 2000 and 2007 were classed as rare, according to updated epidemiologic information from the Information Network on Rare Cancers.

The 70-gene MammaPrint assay can identify women who have an ultralow risk for death from breast cancer in the long term, potentially allowing their physicians to choose less aggressive treatment, say researchers.

All-cause and prostate cancer-specific mortality rates remain comparable over nearly 2 decades of follow-up among men with early prostate cancer regardless of whether they undergo radical prostatectomy or observation, the PIVOT trial shows.

medwireNews brings you news and conference reports from the ESMO 2016 Congress, held in Copenhagen, Denmark.

Click through to read the full reports of the latest research.

Visit our dedicated microsite for research news, interviews and in-depth analysis of paediatric endocrinology and growth disorders.

Highlights from the 1st conference of the European Academy of Neurology in Berlin, Germany.

Click through to read research news from the conference.